124 related articles for article (PubMed ID: 9457816)
1. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers.
Robertson C; Robertson AG; Hendry JH; Roberts SA; Slevin NJ; Duncan WB; MacDougall RH; Kerr GR; O'Sullivan B; Keane TJ
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):319-29. PubMed ID: 9457816
[TBL] [Abstract][Full Text] [Related]
2. Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: a linear quadratic analysis.
Robertson AG; Robertson C; Perone C; Clarke K; Dewar J; Elia MH; Hurman D; MacDougall RH; Yosef HM
Radiother Oncol; 1998 Aug; 48(2):165-73. PubMed ID: 9783888
[TBL] [Abstract][Full Text] [Related]
3. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
[TBL] [Abstract][Full Text] [Related]
4. Time factors in larynx tumor radiotherapy: lag times and intertumor heterogeneity in clinical datasets from four centers.
Roberts SA; Hendry JH
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1247-57. PubMed ID: 10613320
[TBL] [Abstract][Full Text] [Related]
5. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
[TBL] [Abstract][Full Text] [Related]
6. The role of postradiotherapy neck dissection in supraglottic carcinoma.
Chan AW; Ancukiewicz M; Carballo N; Montgomery W; Wang CC
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):367-75. PubMed ID: 11380223
[TBL] [Abstract][Full Text] [Related]
7. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy.
Slevin NJ; Hendry JH; Roberts SA; Agren-Cronqvist A
Radiother Oncol; 1992 Aug; 24(4):215-20. PubMed ID: 1410576
[TBL] [Abstract][Full Text] [Related]
8. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer.
Barton MB; Keane TJ; Gadalla T; Maki E
Radiother Oncol; 1992 Mar; 23(3):137-43. PubMed ID: 1574592
[TBL] [Abstract][Full Text] [Related]
9. Local control of T3 carcinomas after accelerated fractionation: a look at the "gap".
Wang CC; Efird J; Nakfoor B; Martins P
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):439-41. PubMed ID: 8655365
[TBL] [Abstract][Full Text] [Related]
10. 331 cases of clinically node-negative supraglottic carcinoma of the larynx: a study of a modest size fixed field radiotherapy approach.
Sykes AJ; Slevin NJ; Gupta NK; Brewster AE
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1109-15. PubMed ID: 10725620
[TBL] [Abstract][Full Text] [Related]
11. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
12. Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment?
Garden AS; Forster K; Wong PF; Morrison WH; Schechter NR; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):322-8. PubMed ID: 12527044
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy for larynx carcinoma: long-term results of stage I glottic carcinoma.
Chatani M; Matayoshi Y; Masaki N
Strahlenther Onkol; 1993 Feb; 169(2):102-6. PubMed ID: 8451724
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of radical radiotherapy alone for functional preservation of larynx in laryngeal carcinoma: a retrospective analysis.
Bhattacharyya T; Ghoshal S; Dhanireddy B; Kumar R; Sharma SC
Indian J Cancer; 2014; 51(1):10-4. PubMed ID: 24947088
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy.
Rezvani M; Fowler JF; Hopewell JW; Alcock CJ
Br J Radiol; 1993 Mar; 66(783):245-55. PubMed ID: 8472118
[TBL] [Abstract][Full Text] [Related]
16. Modelling the optimal radiotherapy regime for the control of T2 laryngeal carcinoma using parameters derived from several datasets.
Roberts SA; Hendry JH; Slevin NJ
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1173-82. PubMed ID: 9392560
[TBL] [Abstract][Full Text] [Related]
17. Overall time in telecobalt therapy for T1 glottic carcinoma treated with 2 Gy per day.
Inoue T; Inoue T; Teshima T; Murayama S; Yamazaki H; Nose T; Tanaka E
Strahlenther Onkol; 1995 Aug; 171(8):475-7. PubMed ID: 7652672
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma of the larynx treated with hypofractionated radiation and hyperbaric oxygen: long-term tumor control and complications.
Haffty BG; Hurley RA; Peters LG
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):13-20. PubMed ID: 10477001
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy in management of carcinoma of the vulva with emphasis on conservation therapy.
Perez CA; Grigsby PW; Galakatos A; Swanson R; Camel HM; Kao MS; Lockett MA
Cancer; 1993 Jun; 71(11):3707-16. PubMed ID: 8490921
[TBL] [Abstract][Full Text] [Related]
20. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma.
Kwong DL; Sham JS; Chua DT; Choy DT; Au GK; Wu PM
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):703-10. PubMed ID: 9336153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]